公开(公告)号：EP0760240B1

公开(公告)日：2005-10-12

申请号：EP96909178.4

申请日：1996-04-10

申请人： Decox, S.L.

发明人： LAZARO FLORES, Consuelo ,  CALVO LAZARO, Paula ,  CALVO LAZARO, Elena ,  MANRESA FERRERO, Maria Teresa ,  CALVO MONDELO, Fernando

IPC分类号： A61K31/52 ,  A61K35/78 ,  A61K31/4375 ,  A61P25/26

CPC分类号： A23G1/56 ,  A23F3/30 ,  A23F5/40 ,  A23G2200/00 ,  A23G2200/14 ,  A23L2/52 ,  A61K31/4375 ,  A61K31/519 ,  A61K31/522 ,  A61K36/185 ,  A61K36/258 ,  A61K36/74 ,  A61K36/752 ,  A61K31/475 ,  A61K2300/00

摘要： The present invention is based on the discovery of the potent action that certain alcaloids with an eburnamenine nucleus have when they are administered in association with compounds having a xantine structure. A synergic potent action in the cognoscitive capacity is obtained and, consequently the cerebral activity is reinforced in general in the short and long term following the oral administration of the patented composition. The disclosed composition contains quantities comprised between 0.5 and 10 mg of alcaloids or extract of alcaloids of the eburnamenine type per 100 ml of beverage of cola, lemon, cocoa, ginseng, tonic water, coffee or any other beverage obtained from extracts, in quantities comprised between 0.4 and 30 mg of alcaloids or extracts, of alcaloids of the eburnamenine type per each 5-20 g of dry, semi-dry or wet extract of coffee, cola, cocoa, tea, ginseng, tonic water or any other extract for beverages.

公开(公告)号：EP0760240A1

公开(公告)日：1997-03-05

申请号：EP96909178.4

申请日：1996-04-10

申请人： Decox, S.L.

发明人： LAZARO FLORES, Consuelo ,  CALVO LAZARO, Paula ,  CALVO LAZARO, Elena ,  MANRESA FERRERO, Maria Teresa ,  CALVO MONDELO, Fernando

IPC分类号： A61K31/52 ,  A61K35/78

CPC分类号： A23G1/56 ,  A23F3/30 ,  A23F5/40 ,  A23G2200/00 ,  A23G2200/14 ,  A23L2/52 ,  A61K31/4375 ,  A61K31/519 ,  A61K31/522 ,  A61K36/185 ,  A61K36/258 ,  A61K36/74 ,  A61K36/752 ,  A61K31/475 ,  A61K2300/00

摘要： The present invention is based on the discovery of the potent action that certain alcaloids with an eburnamenine nucleus have when they are administered in association with compounds having a xantine structure. A synergic potent action in the cognoscitive capacity is obtained and, consequently the cerebral activity is reinforced in general in the short and long term following the oral administration of the patented composition. The disclosed composition contains quantities comprised between 0.5 and 10 mg of alcaloids or extract of alcaloids of the eburnamenine type per 100 ml of beverage of cola, lemon, cocoa, ginseng, tonic water, coffee or any other beverage obtained from extracts, in quantities comprised between 0.4 and 30 mg of alcaloids or extracts, of alcaloids of the eburnamenine type per each 5-20 g of dry, semi-dry or wet extract of coffee, cola, cocoa, tea, ginseng, tonic water or any other extract for beverages.

摘要翻译： 本发明是基于有效的作用的发现也与象牙烯宁核具有当他们相关联施用与具有黄嘌呤结构的化合物的某些alcaloids。 在cognoscitive容量的协同有效的行动得到，因此大脑活动被普遍增强短期和长期继专利成分的口服给药。 盘游离缺失组合物含有0.5至10毫克alcaloids或每100毫升的可乐，柠檬，可可，人参，奎宁水，咖啡或任何其它饮料从提取物中得到的饮料的象牙烯宁型的alcaloids的提取物之间包含数量时，在由数量 0.4和30mg alcaloids或提取物，每各5-20克的咖啡，可乐，可可，茶，人参，奎宁水或任何其他提取物饮料干燥，半干燥或湿提取物的象牙烯宁型的alcaloids的之间 ，